ALEC - Alector, Inc.
2.16
0.110 5.093%
Share volume: 437,289
Last Updated: 05-12-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.21%
PREVIOUS CLOSE
CHG
CHG%
$2.05
0.11
0.05%
View ratios
| Fiscal Date | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | 03-31-2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
| Report Date | 08-07-2024 | 11-06-2024 | 02-26-2025 | 05-08-2025 | 08-07-2025 | 11-06-2025 | 02-25-2026 | 05-07-2026 | |
| Assets | |||||||||
| Total Assets | 570.729 M | 516.023 M | 468.303 M | 408.303 M | 356.422 M | 335.285 M | 293.237 M | 239.916 M | |
| Current Assets | 519.701 M | 469.364 M | 424.817 M | 366.650 M | 319.178 M | 300.385 M | 266.452 M | 215.084 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 455.789 M | 420.043 M | 380.376 M | 316.578 M | 262.509 M | 214.605 M | 190.222 M | 129.553 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 47.545 M | 37.159 M | 33.021 M | 37.973 M | 44.771 M | 76.503 M | 65.802 M | 76.962 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 19.950 M | 18.216 M | 17.145 M | 16.207 M | 13.914 M | 12.714 M | 10.841 M | 9.934 M | |
| Other Assets | 31.078 M | 28.443 M | 26.341 M | 25.446 M | 23.330 M | 22.186 M | 15.944 M | 14.898 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 570.729 M | 516.023 M | 468.303 M | 408.303 M | 356.422 M | 335.285 M | 293.237 M | 239.916 M | |
| Total liabilities | 420.162 M | 397.090 M | 341.503 M | 313.693 M | 285.247 M | 277.573 M | 262.588 M | 229.534 M | |
| Total current liabilities | 147.682 M | 142.525 M | 125.059 M | 109.773 M | 84.354 M | 79.964 M | 69.503 M | 40.965 M | |
| Accounts Payable | 4.375 M | 5.017 M | 2.215 M | 2.326 M | 2.217 M | 4.757 M | 1.691 M | 1.423 M | |
| Other liabilities | 72.897 M | 61.790 M | 34.886 M | 24.148 M | 22.487 M | 20.729 M | 19.225 M | 17.416 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 9.389 M | 9.464 M | 9.536 M | 9.611 M | 9.323 M | 8.287 M | |
| Other liabilities | 72.897 M | 61.790 M | 34.886 M | 24.148 M | 22.487 M | 20.729 M | 19.225 M | 17.416 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 150.567 M | 118.933 M | 126.800 M | 94.610 M | 71.175 M | 57.712 M | 30.649 M | 10.382 M | |
| Common stock | 936.020 M | 945.055 M | 955.666 M | 964.017 M | 971.201 M | 992.304 M | 1.003 B | 1.005 B | |
| Retained earnings | -784.833 M | -827.053 M | -829.127 M | -869.598 M | -900.122 M | -934.789 M | -972.056 M | -994.986 M |